Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
When To Choose Cash Back Over Points On Credit Cards
Knowing when to choose cash back over points on credit cards can save you money. Learn the scenarios that favor cash back!
27,373 articles
Cathie Wood Goes Selling: Three Stocks She Just Trimmed
Cathie Wood's selling moves can offer valuable lessons for investors. This article breaks down why cathie wood goes s...
Amazon Tops Mag 7 as Stock Heads Into Q2 Earnings Outlook
Jefferies positions Amazon as the leading Mag 7 stock headed into earnings, underscoring AWS momentum, Prime Day stre...
A Larger Social Security Check Could Arrive in 2027
Inflation trends point to a possible larger social security check in 2027, yet higher health care costs and taxes may...
Celsius Pulled Massive Steal: A Multi-Brand Investment Play
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...
Finally Buy Joby Aviation Down From Peak? A Look Ahead
Joby Aviation has moved lower after hitting a peak. This guide weighs the risks and potential catalysts, and offers a...
Intuitive Surgical Upgraded by Citi Signals New Buy Cycle
Citi upgrades Intuitive Surgical to Buy as market volatility eases, with Stryker placed on a 90-day catalyst watch an...
Morning Minute: Circle Plunges 20% as Clarity Act Shifts Markets
A sharp 20% plunge in Circle tokens sparked by yield shifts under a new Clarity Act framework. This morning minute re...
Capricor's Insider Just Sold: Read the Signals for Investors
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
Beaten Down AI Infrastructure Stocks Eye a June Rebound Today
As AI infrastructure names retreat from spring highs, June market conditions and resilient AI demand are prompting in...
Team Star Ricardo Pepi: From Trailer to World Cup Dream
From a modest El Paso trailer to the World Cup stage, Ricardo Pepi’s journey spotlights the hidden costs of chasing a...
AppLovin Could $600+ with AI Ad-Tech Rebound: Stock Outlook
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status